| 发明名称 |
Compositions and methods for the prevention and treatment of cardiovascular diseases |
| 摘要 |
Compositions comprising electro-activated aqueous solutions and methods for the prevention and treatment of dysfunctional cardiovascular conditions are provided. |
| 申请公布号 |
US9089602(B2) |
申请公布日期 |
2015.07.28 |
| 申请号 |
US201414550691 |
申请日期 |
2014.11.21 |
| 申请人 |
REVEN PHARMACEUTICALS, INC. |
发明人 |
Van Wyk Henk;Van Wyk Mariette;Krebs Trace;Lange Peter;Denomme Brian;Volk Michael A. |
| 分类号 |
A61K33/14;A61K41/00;A61K31/375;A61K33/06;A61K31/167;A61K31/455;A61K31/4415;A61K31/675;A61K31/51;A61K31/714 |
主分类号 |
A61K33/14 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. A stable therapeutic composition comprising an electro-activated solution, wherein the electro-activated solution has an oxidation-reduction potential (ORP) in the range between −500 mV and −900 mV for a period of at least 12 months and a pH in the range between 3.2 and 4.5, and the composition comprises:
Ascorbic acid 83.6-95.5 g/L; Magnesium Sulphate hexahydrate 57.1-64.7 g/L; 2-diethylaminoaceto,xylidide 31.5-37.5 g/L; Niacinamide 9.4-10.7 g/L; Pyridoxin HCL 9.4-10.7 g/L; Riboflavin-5-phosphate sodium 0.18-0.2 g/L; Thiamin HCL 5.75-6.5 g/L; Cyanocobalamin crystalline 0.17-0.2 g/L; and Electrochemically activated water+. |
| 地址 |
Golden CO US |
